Conquest Research, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Conquest Research, LLC - overview
Established
2018
Location
Winter Park, FL, US
Primary Industry
Pharmaceuticals
About
Based in Florida, US, and founded in 2018, Conquest Research provides clinical research in a cost-effective and timely manner. As of 2023, the company is headed by its CEO Mark Daley. In September 2023, Reynolda Equity Partners acquired a majority stake in Conquest Research, LLC through a recapitalization. The company offers pharmaceutical clinical research solutions such as pharmaceutical research and development, clinical trials, and patient engagement.
The firm provides its services to pharmaceutical companies, physicians, and many more. Firm few of the current studies are Ankylosing Spondylitis, Osteoarthritis of the Knee, Migraines, Lumbar Disc Herniation, and many others.
Current Investors
Reynolda Equity Partners
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.conquestresearch.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Conquest Research, LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Neurotrials Research, Inc. | - | ||||||||
| Add-on | Completed | Sana Research | - | ||||||||
| Recapitalisation | Completed | Conquest Research, LLC | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.